LIPAGLYN - The novel drug for treating Diabetic Dyslipidemiacombines lipid and glucose lowering effects in one single molecule.
Terms Of Usage
These terms were last revised on 09/09/2015.
This website is maintained by Cadila Healthcare Limited. ("Zydus").
Nothing on this website should be construed as the giving of advice or the making of a recommendation regarding any decision or action related to your health or the health of others. If you are a patient, you should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any treatment decisions. If you are a doctor or other qualified health care professional, you should not allow the content of this website to substitute for your own medical judgment, which you should exercise in evaluating the information on this website.
This website may contain information brought to you by third parties or through links to other Internet websites. Notice of information or links of this kind is provided throughout the website. Cadila Healthcare Limited does not control nor assume any responsibility for the information provided by third parties or the content of other Internet websites to which we provide links.